ROBERTSON GLOBAL HEALTH SOLUTIONS CORP - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - May 9, 2012

Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR10.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR14.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR13.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR11.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR12.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR4.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR1.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR3.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR7.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR6.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR2.htm
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR8.htm
EXCEL - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPR9.htm
EX-32.1 - EXHIBIT 32.1 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPex32-1.htm
EX-31.2 - EXHIBIT 31.2 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPex31-2.htm
EX-31.1 - EXHIBIT 31.1 - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPex31-1.htm
10-Q - FORM 10Q - ROBERTSON GLOBAL HEALTH SOLUTIONS CORPrghs_10q-033112.htm
v2.4.0.6
Consolidated Statements of Cash Flows (unaudited) (USD $)
 6 Months Ended 84 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Operating activities      
Net loss $ (677,823) $ (1,705,941) $ (17,553,970)
Adjustments to reconcile net loss to net cash used by operating activities:      
Depreciation 967 875 45,011
Amortization of deferred rent and facility exit liability (32,329) (20,545) (97,613)
Adjustment of accrued facility exit liability   16,017 31,038
Unrealized gain on derivative revaluation     (17,279)
Impairment expense     1,548,375
(Gain) loss on sale of assets (60) 2,878 2,818
Gain on debt cancellation     (262,088)
Note discount accretion   18,000 128,413
Beneficial conversion of convertible debt     89,048
Value of warrants issued for note guarantee     16,384
Stock based compensation 107,209 457,596 1,072,164
Changes in:      
Accounts receivable 31,122   (10,378)
Accounts receivable - related parties (41,921) (9,996) (83,352)
Prepaid and other 25,454 16,250 (2,932)
Accounts payable and accrued expenses 151,513 368,305 4,164,935
Deposits     (3,747)
Deferred revenue 16,667   48,167
Accrued interest 55,431 39,661 365,582
Net cash used by operating activities (363,770) (816,900) (10,519,424)
Investing activities      
Purchase of property and equipment (1,346) (4,663) (53,555)
Proceeds from sale of assets   543,747 843,747
Cash received in merger transaction     243,296
Net cash provided (used) by investing activities (1,346) 539,084 1,033,488
Financing activities      
Net change in stockholder advances   50,000 150,000
Sale of common stock 190,000 210,000 8,722,500
Sale of warrants   178,375 178,375
Repurchase of common stock     (372,000)
Proceeds from exercise of warrants     75,000
Payment of fractional shares     (4,321)
Proceeds from exercise of stock options     1,800
Proceeds from issuance of debt 140,000   1,335,416
Repayment of debt (46,566) (145,432) (591,931)
Net cash provided by financing activities 283,434 292,943 9,494,839
Net increase (decrease) in cash (81,682) 15,127 8,903
Cash, beginning of period 90,585 40,976  
Cash, end of period 8,903 56,103 8,903
SUPPLEMENTAL CASH-FLOW INFORMATION      
Cash paid for interest 13,130 18,211 195,664
Transfers of liabilities from affiliate for costs incurred     824,053
Derivative liability recorded for warrants     17,279
Repayment of advances from proceeds from sale of assets   150,000 150,000
Issuance of stock on conversion of debt     741,215
Non-cash payment on accounts payable 725   725
Redemption of Accrued Liabilities [Member]
      
SUPPLEMENTAL CASH-FLOW INFORMATION      
  137,188 806,005
Redemption of Accounts Payable [Member]
      
SUPPLEMENTAL CASH-FLOW INFORMATION      
$ 25,967   $ 25,967

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by ROBERTSON GLOBAL HEALTH SOLUTIONS CORP and has no official or unofficial affiliation with ROBERTSON GLOBAL HEALTH SOLUTIONS CORP


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.